NVS Today - Aug 12: Weaker Earnings Forecasts
Impossibile aggiungere al carrello
Puoi avere soltanto 50 titoli nel carrello per il checkout.
Riprova più tardi
Riprova più tardi
Rimozione dalla Lista desideri non riuscita.
Riprova più tardi
Non è stato possibile aggiungere il titolo alla Libreria
Per favore riprova
Non è stato possibile seguire il Podcast
Per favore riprova
Esecuzione del comando Non seguire più non riuscita
-
Letto da:
-
Di:
A proposito di questo titolo
So, what went down? The stock got smoked today, and honestly, it felt like a slow bleed. It opened up okay but just kinda drifted downwards throughout the day. Nothing too wild in the volume, just your usual trading action.
Now, let’s get into why this happened. The big news is that Erste Group Bank threw out a forecast saying Novartis is looking at weaker earnings ahead. That kind of news? Yeah, it makes investors nervous. People hit the sell button fast when they hear stuff like that, especially when the market is already a bit shaky. Plus, there’s been chatter about layoffs in the biotech space, which has folks wondering about the stability of companies like Novartis. And then, there’s that deal with Dr. Reddy’s in India that’s set to end soon, which adds to the uncertainty. All these factors piled up and led to some selling pressure.
On a slightly brighter note, Novartis is working on optimizing its supply chain. That’s a solid move in the long run, but right now, it feels overshadowed by the earnings forecast.
To wrap it up, Novartis had a rough day, mainly due to some weak earnings chatter and industry concerns. Just remember, this info is for your entertainment and to keep you in the loop, not financial advice. Catch you later!
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione